- Home
- EXEL vs ELS Comparison
EXEL vs ELS Comparison
Compare EXEL & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ELS
- Stock Information
- Founded
- EXEL 1994
- ELS 1992
- Country
- EXEL United States
- ELS United States
- Employees
- EXEL N/A
- ELS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ELS Real Estate Investment Trusts
- Sector
- EXEL Health Care
- ELS Real Estate
- Exchange
- EXEL Nasdaq
- ELS Nasdaq
- Market Cap
- EXEL 10.4B
- ELS 11.7B
- IPO Year
- EXEL 2000
- ELS 1993
- Fundamental
- Price
- EXEL $40.35
- ELS $60.22
- Analyst Decision
- EXEL Buy
- ELS Buy
- Analyst Count
- EXEL 22
- ELS 11
- Target Price
- EXEL $44.00
- ELS $71.05
- AVG Volume (30 Days)
- EXEL 2.3M
- ELS 1.5M
- Earning Date
- EXEL 10-28-2025
- ELS 10-20-2025
- Dividend Yield
- EXEL N/A
- ELS 3.40%
- EPS Growth
- EXEL 81.76
- ELS 1.09
- EPS
- EXEL 2.08
- ELS 1.94
- Revenue
- EXEL $2,230,005,000.00
- ELS $1,534,019,000.00
- Revenue This Year
- EXEL $9.19
- ELS $1.54
- Revenue Next Year
- EXEL $12.54
- ELS $3.66
- P/E Ratio
- EXEL $19.56
- ELS $31.32
- Revenue Growth
- EXEL 10.73
- ELS 1.05
- 52 Week Low
- EXEL $25.17
- ELS $58.15
- 52 Week High
- EXEL $49.62
- ELS $75.69
- Technical
- Relative Strength Index (RSI)
- EXEL 61.73
- ELS 46.80
- Support Level
- EXEL $38.37
- ELS $60.23
- Resistance Level
- EXEL $40.78
- ELS $61.45
- Average True Range (ATR)
- EXEL 1.01
- ELS 0.96
- MACD
- EXEL 0.41
- ELS -0.01
- Stochastic Oscillator
- EXEL 91.21
- ELS 39.18
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.